Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-12-10 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
第九届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the first meeting of the ninth board of directors of Ningbo Xinzhi Biotechnology Co., Ltd. It includes election and appointment of board chairman, vice chairman, committee members, general manager, deputy general manager, board secretary, financial officer, internal audit head, and securities affairs representative. It also covers a capital increase and reduction proposal for a subsidiary. The document is dated December 11, 2025, and contains voting results and compliance statements. It is clearly a board meeting resolution announcement related to changes in board and senior management positions and other corporate governance matters. There is no financial data or earnings information, nor is it a report or presentation. The content fits the category of Board/Management Information (MANG). The document length is about 4700 characters, which is sufficient for a full announcement rather than a brief notice. Therefore, the classification is MANG with high confidence.
2025-12-10 Chinese
关于选举公司第九届董事会专门委员会委员的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of members to the company's ninth board of directors' specialized committees. It details the composition of the audit, nomination, remuneration, and strategy committees, their members, and the legal compliance of the election process. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting presentation or voting results. The content is about board/management structure and governance. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2025-12-10 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Ningbo New Gen Bio-tech Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It includes specifics about authorized cash management, types of financial products invested in, amounts, expected yields, investment terms, risk control measures, and lists of ongoing and matured cash management products. The document references board and shareholder meeting approvals related to the cash management plan. It is not a financial report like an annual or interim report, nor is it a call transcript or earnings release. It is a regulatory announcement about the company's capital management activities, specifically the use of idle raised funds for cash management. This fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage. The document length is substantial and contains detailed data, not just a brief notice or certification, so it is not RNS or RPA. Therefore, the classification is CAP with high confidence.
2025-11-26 Chinese
关于召开 2025 年第二次临时股东会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2025 second extraordinary general meeting of shareholders for Ningbo Scientz Biotechnology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items such as election of directors and appointment of accounting firms, registration procedures, and proxy authorization forms. The document does not contain financial statements or results but serves as an official announcement to shareholders about the meeting and voting process. It is not a report of voting results, nor a management or financial report. Given the content and purpose, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to the Annual or Extraordinary General Meeting, including notices and meeting agendas.
2025-11-19 Chinese
独立董事提名人声明与承诺
Board/Management Information Classification · 95% confidence The document is a nomination statement and commitment declaration for independent director candidates of Ningbo Xinzhi Biotechnology Co., Ltd. It details the qualifications, independence criteria, and legal compliance of the nominees. There are no financial statements, earnings data, or report attachments. The document is an announcement related to board/management changes, specifically the nomination of independent directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is 2626 characters, which is relatively short and consistent with an announcement rather than a full report.
2025-11-19 Chinese
独立董事候选人声明与承诺（毛磊）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate (毛磊) for 宁波新芝生物科技股份有限公司. It contains detailed personal qualifications, compliance with laws and regulations, and commitments related to the independent director role. There are no financial statements, earnings data, or report summaries. It is not an announcement of voting results or a proxy solicitation. It is a regulatory compliance document related to board/management information, specifically about a board candidate's qualifications and declarations. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on a single candidate's declaration, confirming it is not a full report or announcement of a report publication.
2025-11-19 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.